🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
SciVision Biotech Inc. (TPE:1786)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
40.35
-1.35 (-3.24%)
Nov 20, 2026, 1:30 PM CST

SciVision Biotech Cash Flow Statement

Millions TWD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
142.82162.34242.25177.9141.72101.72
Depreciation & Amortization
90.7880.3665.1463.0562.0252.98
Other Amortization
0.070.070.080.080.040.04
Loss (Gain) From Sale of Assets
00.01-0.19-0.54-30.55-0.13
Loss (Gain) From Sale of Investments
10.562.13-6.45-2.91.980.13
Other Operating Activities
8.75-4.0725.997.4318.12-2.23
Change in Accounts Receivable
-75.46-75.5-73.55-4.85-7.77-10.47
Change in Inventory
-12.53-13.7414.458.62-13-37.03
Change in Accounts Payable
-14.613.136.52-3.216.77-11.33
Change in Unearned Revenue
8.75-1.13-4.346.32-1.01-5.6
Change in Other Net Operating Assets
-61.76-29.6-0.0420.113.6810.41
Operating Cash Flow
97.37123.99269.87272.01181.9998.51
Operating Cash Flow Growth
-59.06%-54.06%-0.79%49.47%84.75%-22.11%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-101.53-101.53-34.76-14.73-14.96-25.78
Sale of Property, Plant & Equipment
--0.191.2656.4821.13
Sale (Purchase) of Intangibles
-0.67-0.23-0.12-0.11--
Investment in Securities
-104.05-39.79134-201.79-48.49-20.89
Other Investing Activities
2.18-1.19-1.792.0152.79-51.47
Investing Cash Flow
-138.65-142.7497.52-213.3745.81-77.01

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Short-Term Debt Issued
-2---10
Long-Term Debt Issued
-400--7001,200
Total Debt Issued
-402--7001,210
Short-Term Debt Repaid
--1.49----10
Long-Term Debt Repaid
--8.1-3.35-1.23-905.89-901.39
Lease Payments
-10.93-8.1-3.35-1.23-1.37-1.39
Total Debt Repaid
-11.94-9.6-3.35-1.23-905.89-911.39
Net Debt Issued (Repaid)
-11.94392.4-3.35-1.23-205.89298.61
Repurchase of Common Stock
-123.01-----
Common Dividends Paid
-142.84-233.87-169.33-133.3-93.83-58.56
Other Financing Activities
--0.16-0.01-
Financing Cash Flow
-277.78158.53-172.52-134.53-299.71240.06

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
0.1900.05-0.030.01-0.01
Net Cash Flow
-318.87139.79194.92-75.92-71.9261.55

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-4.1622.46235.11257.28167.0372.73
Free Cash Flow Growth
--90.45%-8.62%54.04%129.64%21.97%
Free Cash Flow Margin
-0.48%2.53%26.62%36.08%29.97%14.39%
Free Cash Flow Per Share
-0.050.293.163.372.241.02
Levered Free Cash Flow
46.1-82.15134.06189.2199.159.36
Unlevered Free Cash Flow
53.91-77.19137.61194.35103.1814.4
Free Cash Flow After Leases
-15.0914.36231.76256.05165.6671.35

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
0.030.030.990.422.991.12
Cash Income Tax Paid
38.0338.0328.630.9711.5123.53
Change in Working Capital
-155.61-116.84-56.9626.99-11.33-54.01